||Hilton Orlando Hotel
||Thursday, May 30, 2013 8:00 PM
||To register scroll down.
The CMSC, ACTRIMS, and NPA do not certify this program for Continuing Education Credit and do not take responsibility for the quality or evidence upon which the content has been based or the faculty chosen.
MS is a chronic, progressive, inflammatory, and neurodegenerative disease of the central nervous system that leads to significant disability. The push towards ever earlier diagnosis and treatment of MS and the rapid emergence of novel agents are causing considerable changes to the management of the disease. The decisions regarding when to initiate treatment and which agents to use, along with deliberations on long-term management, are all increasingly difficult, with adherence issues continuing to negatively impact outcomes and add to the intricacy of MS treatment. The emerging data on biomarker research, aimed at increasing diagnostic accuracy and aiding in management, adds to the complexity of decision-making in MS.
This program provides neurologists and MS specialists with updates on the latest advances in MS diagnosis and management, so that they can optimize outcomes for their patients with MS.
Suhayl Dhib-Jalbut, MD
Professor and Chairman
Department of Neurology
UMDNJ-Robert Wood Johnson Medical School
Chief, Neurology Service
Robert Wood Johnson University Hospital
New Brunswick, NJ
Clyde E. Markowitz, MD
Chief, MS Section
Director, MS Center
Associate Professor of Neurology
Perelman School of Medicine
University of Pennsylvania
Aaron E. Miller, MD
Professor of Neurology
Medical Director, The Corinne Goldsmith Dickinson
Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, NY
This activity is intended for neurologists, MS nurses, and other health care providers actively involved in the care of patients with multiple sclerosis.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Describe the mechanisms of action and efficacy and safety profiles of current and emerging DMD therapies in MS
- Select and initiate effective DMD therapies earlier in the course of MS
- Provide patient-tailored therapy to optimize adherence, increase effectiveness, and improve patient outcomes
- Apply improved MRI measures and diagnostic biomarkers to allow for earlier diagnosis of MS
- Assess the clinical utility of MRI measures and biomarkers to monitor disease activity and response to DMD therapy
|Dessert & Registration:
||8:00pm – 8:30pm
||8:30pm – 9:45pm
|8:00 – 8:30pm
||Registration and Dessert
|8:30 – 8:35pm
||Welcome and Introduction
|8:35 – 8:55pm
||Improving Early Diagnosis and Assessment in MS – Dr. Markowitz
|8:55 – 9:15pm
||Individualizing DMD Therapy to Improve Adherence – Dr. Miller
|9:15 – 9:35pm
||Current and Evolving Biomarkers in MS – Dr. Dhib-Jalbut
|9:35 – 9:45pm
||Case Panel Discussion/Q&A Session and Concluding Remarks – Faculty Panel
Physicians – This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Nurses – Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Physicians – The Potomac Center for Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, evaluation, please email firstname.lastname@example.org.
Nurses – This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the nursing accreditation of this program, please contact Global at email@example.com or 303-395-1782.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Method of Participation
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME/CE certificate will be provided by onsite staff upon submission of a completed evaluation form.
There are no fees associated with this program.
Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.). Please email firstname.lastname@example.org at least 5 days prior to the program.
Jointly Sponsored By
Supported by an independent medical educational grant from:
By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.
Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.